References
Dewey RB, Reimold SC, O’Suilleabhain PE (2007) Cardiac valve regurgitation with pergolide compared with non- ergot agonists in Parkinson’s disease. Arch Neurol 64:377–380
Línková H, Růžička E, Pěnička M (2007) Dopamine agonists and valvular heart disease-letter to the editor. N Engl J Med 356:16
Růžička E, Línková H, Pěnička M, Ulmanová O, Nováková L, Roth J (2007) Low incidence of restrictive valvulopathy in patients with Parkinson’s disease on moderate dose of pergolide. J Neurol 254(11):1575–1578
Simonis G, Fuhrmann JT, Strasser RH (2007) Meta-analysis of heart valve abnormalities in Parkinson’s disease patients treated with dopamine agonists. Mov Disord 22(13):1936–1942
Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G (2007) Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. N Engl J Med 356:39–46
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bareš, M., Rektorová, I., Krajčovičová, L. et al. Heart valve abnormalities in Parkinson’s disease treated with dopamine agonists. J Neurol 255, 1596 (2008). https://doi.org/10.1007/s00415-008-0972-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0972-x